Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Listen to these webinars


Digital Health Revolution:
Hear experts from the medical devices and pharmaceuticals industries present crucial information about the continuing evolution of today’s digital health landscape:

  • Lucie Ellis, Executive Editor, In Vivo “Digital Health Today”
  • Derrick Gingery, Senior Write, Pink Sheet “Using Digital Health to Approve Drugs”
  • Zach Rothstein, VP of Technology and Regulatory Affairs, AdvaMed “FDA Regulations, Cybersecurity, and AI”
  • Ferdous Al-Faruque, Senior Reporter, Medtech Insight “Latest Developments in Digital Health”

FDA and its Commissioners:
Nancy Myers, President and Founder Catalyst Healthcare Consulting and former FDA executive and Nielsen Hobbs, Executive Editor Pink share their insights on the FDA of yesterday and tomorrow, covering topics such as:

  • How Gottlieb changed the FDA
  • Further reforms on the horizon
  • How much will FDA focus on drug pricing
  • Wait-time trends for commissioners
  • What the administration is looking for in a new commissioner

Manufacturing Challenges Facing Cell and Gene Therapy:
Detailed insights and industry best practices from preeminent sector experts provide a deeper understanding of the many manufacturing and industrialization hurdles unique to bringing durable and even curative therapies to patients in need. Moderated by Datamonitor Healthcare Senior Advisor, Amana Micklus, this webinar features presentations and roundtable discussion from:

  • Michael Lehmicke, Director, Science and Industry Affairs for Alliance for Regenerative Medicine
  • David DiGuisto, Chief Technical Officer, Semma Therapeutics
  • Michelle Berg, President GMP Nucleic Acids Aldevron
  • Robert Preti, CEO and President, Hitachi Chemical Advanced Therapeutic Solutions and General Manager Hitachi Chemical Regenerative Medicine Business Sector

What’s the Reality of Real-World Evidence?:
Hear directly from pharma industry leaders about their own experiences of using real world evidence (RWE) in a variety of applications. Moderated by Scrip Executive Editor, Mary Jo Laffler, the session also features RWE insights from Pink Sheet’s Managing editor, Bridget Silverman, who will be joined by senior executives from top pharma companies. Topics include:

  • FDA’s RWE Framework & what it means for industry
  • Review of FDA’s acceptance of RWE in approvals
  • Panel discussion on the effects of RWE on regulatory, clinical and commercial strategy, with GlaxoSmithKline’s Head of US Value, Evidence and Outcomes, Ben Gutierrez, and Merck KGAA’s Global Head of Epidemiology, Patrice Verpillat

Complete the form to listen to these webinars!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies